688578 Stock Overview
Shanghai Allist Pharmaceuticals Co., Ltd. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 3/6 |
| Past Performance | 6/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
No risks detected for 688578 from our risk checks.
My Notes
Capture your thoughts, links and company narrative
Shanghai Allist Pharmaceuticals Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥61.59 |
| 52 Week High | CN¥68.87 |
| 52 Week Low | CN¥32.25 |
| Beta | 0.52 |
| 1 Month Change | 9.88% |
| 3 Month Change | 50.29% |
| 1 Year Change | 49.45% |
| 3 Year Change | 116.26% |
| 5 Year Change | n/a |
| Change since IPO | 59.77% |
Recent News & Updates
Shanghai Allist Pharmaceuticals Co., Ltd.'s (SHSE:688578) Intrinsic Value Is Potentially 86% Above Its Share Price
Dec 15
Shanghai Allist Pharmaceuticals Co., Ltd.'s (SHSE:688578) Shares Bounce 43% But Its Business Still Trails The Market
Oct 08Recent updates
Shanghai Allist Pharmaceuticals Co., Ltd.'s (SHSE:688578) Intrinsic Value Is Potentially 86% Above Its Share Price
Dec 15Shanghai Allist Pharmaceuticals Co., Ltd.'s (SHSE:688578) Shares Bounce 43% But Its Business Still Trails The Market
Oct 08Does Shanghai Allist Pharmaceuticals (SHSE:688578) Deserve A Spot On Your Watchlist?
Sep 23Shanghai Allist Pharmaceuticals Co., Ltd. (SHSE:688578) Stock Rockets 34% As Investors Are Less Pessimistic Than Expected
Apr 30Should You Be Adding Shanghai Allist Pharmaceuticals (SHSE:688578) To Your Watchlist Today?
Apr 01Optimistic Investors Push Shanghai Allist Pharmaceuticals Co., Ltd. (SHSE:688578) Shares Up 26% But Growth Is Lacking
Mar 04Shareholder Returns
| 688578 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -4.3% | -1.9% | -1.2% |
| 1Y | 49.5% | -1.8% | 11.8% |
Return vs Industry: 688578 exceeded the CN Pharmaceuticals industry which returned -1.8% over the past year.
Return vs Market: 688578 exceeded the CN Market which returned 11.8% over the past year.
Price Volatility
| 688578 volatility | |
|---|---|
| 688578 Average Weekly Movement | 10.0% |
| Pharmaceuticals Industry Average Movement | 7.4% |
| Market Average Movement | 8.7% |
| 10% most volatile stocks in CN Market | 12.8% |
| 10% least volatile stocks in CN Market | 5.7% |
Stable Share Price: 688578 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 688578's weekly volatility (10%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | 1,044 | Jinhao Du | www.allist.com.cn |
Shanghai Allist Pharmaceuticals Co., Ltd. engages in the research and development of pharmaceutical products in China. It offers pharmaceuticals for the treatment of tumor and cancer diseases. The company was founded in 2004 and is based in Shanghai, China.
Shanghai Allist Pharmaceuticals Co., Ltd. Fundamentals Summary
| 688578 fundamental statistics | |
|---|---|
| Market cap | CN¥27.72b |
| Earnings (TTM) | CN¥1.30b |
| Revenue (TTM) | CN¥3.20b |
21.4x
P/E Ratio8.7x
P/S RatioIs 688578 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 688578 income statement (TTM) | |
|---|---|
| Revenue | CN¥3.20b |
| Cost of Revenue | CN¥164.74m |
| Gross Profit | CN¥3.04b |
| Other Expenses | CN¥1.74b |
| Earnings | CN¥1.30b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 2.88 |
| Gross Margin | 94.86% |
| Net Profit Margin | 40.47% |
| Debt/Equity Ratio | 0% |
How did 688578 perform over the long term?
See historical performance and comparisonDividends
0.8%
Current Dividend Yield23%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/21 04:50 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Shanghai Allist Pharmaceuticals Co., Ltd. is covered by 6 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Feifei Xu | China Merchants Securities Co. Ltd. |
| Zhu Chen | Citic Securities Co., Ltd. |
| Tan Huan Gan | Citic Securities Co., Ltd. |